Friday, 22 March 2019
Latest news
Main » Delphi Management Inc. MA Trims Stake in AbbVie Inc. (ABBV)

Delphi Management Inc. MA Trims Stake in AbbVie Inc. (ABBV)

16 April 2018

Sumitomo Mitsui Trust Holdings Inc. now owns 4,701,437 shares of the company's stock worth $296,520,000 after buying an additional 182,686 shares during the period. The institutional investor is holding 2,658 shares, compared to the 42,422 from the previous quarter. On Monday, October 16 the stock of AbbVie Inc. The stock decreased 0.31% or $0.29 during the last trading session, reaching $91.83. Vanguard Group Inc. raised its holdings in shares of AbbVie by 3.3% in the second quarter. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since April 13, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Bryn Mawr Trust Company decreased its stake in Deere & Co (DE) by 12.92% based on its latest 2017Q4 regulatory filing with the SEC.

In related news, insider Laura J. Schumacher sold 25,000 shares of the firm's stock in a transaction dated Thursday, March 1st. The institutional investor held 10,590 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.02 million, up from 4,668 at the end of the previous reported quarter. Capital Research Global Investors who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $145.71 billion market cap company. About 6.40 million shares traded. Tesla, Inc. (NASDAQ:TSLA) has risen 3.32% since April 15, 2017 and is uptrending. It has underperformed by 0.49% the S&P500.

Since October 30, 2017, it had 0 insider buys, and 12 selling transactions for $49.35 million activity. CHASE WILLIAM J sold 70,928 shares worth $8.31M.

AbbVie (NYSE:ABBV) last released its quarterly earnings results on Friday, January 26th. Another trade for 87,040 shares valued at $8.57 million was made by RICHMOND TIMOTHY J. on Monday, December 18. On Wednesday, February 28 SALEKI-GERHARDT AZITA sold $157,458 worth of AbbVie Inc. Middleton & Co Inc MA grew its stake in shares of AbbVie by 7.2% during the 4th quarter. (NYSE:ABBV) by 4.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. Horseman Capital Management Ltd purchased a new stake in AbbVie in the second quarter valued at about $1,160,000.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.25, from 1.3 in 2017Q3. It dropped, as 42 investors sold ABBV shares while 695 reduced holdings. California State Teachers Retirement Sys holds 0.56% or 2.81M shares. Aspen Investment Management Inc boosted its stake in shares of AbbVie by 0.8% in the 2nd quarter. Mitchell Sinkler Starr Pa invested in 3.1% or 21,638 shares. Notis invested in 1.9% or 34,300 shares. Following the sale, the chief financial officer now directly owns 203,391 shares in the company, valued at $23,833,357.38. Wolverine Asset Ltd Llc invested in 0.04% or 40,000 shares. The Pennsylvania-based Armstrong Henry H Associates Inc has invested 0.41% in AbbVie Inc. Horseman Cap Mngmt Limited has invested 0.43% of its portfolio in AbbVie Inc. Gardner Russo Gardner Lc accumulated 0.01% or 14,100 shares. Abbvie Inc. Com now has $145.71B valuation. (NYSE:ABBV) for 9,583 shares. Flippin Bruce & Porter has 44,050 shares. AbbVie Inc. has a fifty-two week low of $63.12 and a fifty-two week high of $125.86. (NYSE:ABBV). Moreover, Korea Inv has 0.53% invested in AbbVie Inc. The company's revenue was up 13.9% on a year-over-year basis. research analysts predict that AbbVie Inc. will post 7.53 EPS for the current fiscal year. The company reported $1.48 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.44 by $0.04. ABBV's profit will be $2.82 billion for 12.90 P/E if the $1.78 EPS becomes a reality.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 33% are positive. United Parcel Service had 74 analyst reports since July 29, 2015 according to SRatingsIntel. On Friday, February 2 the rating was maintained by Argus Research with "Buy". The company has an average rating of "Buy" and a consensus target price of $117.85. The company was maintained on Monday, November 20 by Cowen & Co. In Friday, January 26 report Jefferies maintained it with "Buy" rating and $150.0 target. On Thursday, April 5 the stock rating was maintained by Barclays Capital with "Equal-Weight". (NYSE:SU) rating on Thursday, January 11. During the same period in the prior year, the firm earned $1.20 earnings per share. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth. Its down 0.05, from 0.85 in 2017Q3. It dived, as 153 investors sold GE shares while 921 reduced holdings. 69 funds opened positions while 206 raised stakes. Finally, Orbis Allan Gray Ltd raised its holdings in shares of AbbVie by 35.7% in the second quarter. (NYSE:UPS) for 201,972 shares. North Mngmt has 139,354 shares. St Johns Invest Mngmt Company Limited Liability Company owns 40 shares or 0% of their U.S. portfolio. Barclays Capital maintained the shares of ABBV in report on Thursday, April 5 with "Equal-Weight" rating. (NASDAQ:TSLA). Dekabank Deutsche Girozentrale owns 11,548 shares for 0.03% of their portfolio. Horan Advsrs Ltd has 0.19% invested in General Electric Company (NYSE:GE). Girard Partners Limited invested in 13,990 shares or 0.26% of the stock. About 4.63 million shares traded. Following the transaction, the vice president now owns 11,170 shares in the company, valued at approximately $1,334,033.10. Michigan-based Plante Moran Financial Limited Liability has invested 0.49% in General Electric Company (NYSE:GE). "Buy" rating has 5, "Sell" are 1, while 6 are "Hold". Therefore 43% are positive. General Electric Company had 97 analyst reports since July 21, 2015 according to SRatingsIntel. On Tuesday, September 22 the stock rating was maintained by Morgan Stanley with "Overweight". The company was maintained on Friday, September 15 by Jefferies. $102,150 worth of Old Republic International Corporation (NYSE:ORI) was bought by REED GLENN W on Thursday, February 15. SunTrust has "Buy" rating and $85 target. On Monday, October 30 the firm has "Outperform" rating given by Leerink Swann. BMO Capital Markets downgraded AbbVie Inc. The rating was upgraded by Citigroup to "Buy" on Tuesday, August 8. On Wednesday, April 12 the stock rating was maintained by Credit Suisse with "Buy".

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.